di-tert-butyl (1R,6S)-2,5-diazabicyclo[4.2.0]octane-2,5-dicarboxylate

Catalog No. :
ACUIET874
CAS No. :
2816820-25-2
Molecular Formula :
C16H28N2O4
Molecular Weight :
312.41

IUPAC Name:di-tert-butyl (1R,6S)-2,5-diazabicyclo[4.2.0]octane-2,5-dicarboxylate

di-tert-butyl (1R,6S)-2,5-diazabicyclo[4.2.0]octane-2,5-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$447.00Login to see priceInquiryInquiry
250mg97%$595.00Login to see priceInquiryInquiry
500mg97%$992.00Login to see priceInquiryInquiry
1g97%$1487.00Login to see priceInquiryInquiry
5g97%$4461.00Login to see priceInquiryInquiry
10g97%$7434.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namedi-tert-butyl (1R,6S)-2,5-diazabicyclo[4.2.0]octane-2,5-dicarboxylate
IUPAC Namedi-tert-butyl (1R,6S)-2,5-diazabicyclo[4.2.0]octane-2,5-dicarboxylate
Molecular FormulaC16H28N2O4
Molecular Weight312.41
SMILESCC(C)(C)OC(=O)N1CCN(C(=O)OC(C)(C)C)[C@H]2CC[C@H]21
InChI KeyNOJMPXVRVLVZAC-TXEJJXNPSA-N
Synonymditert-butyl cis-2,5-diazabicyclo[4.2.0]octane-2,5-dicarboxylate;2,5-Diazabicyclo[4.2.0]octane-2,5-dicarboxylic acid, 2,5-bis(1,1-dimethylethyl) ester, (1R,6S)-
CAS No.2816820-25-2

Synthetic Route by SureRoute

1. ACUIET874 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTKRP176 route compound structure diagram
    ACTKRP1762514607-31-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUIET874 route product structure diagram
    ACUIET8742816820-25-2
Inquiry

2. ACUIET874 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYCJN968 route compound structure diagram
    ACYCJN9682343964-43-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUIET874 route product structure diagram
    ACUIET8742816820-25-2
Inquiry

Comments (0)